Secondaries Investor reports that SEC examiners are requesting fund-specific valuation details as scrutiny of private-fund marks rises. Suppose a GP needs valuation-controls diligence this week, which independent finance or valuation operator can you place quickly?
Secondaries Investor’s "SEC zeroes in on private funds valuations" puts valuation process, documentation and independent challenge into immediate focus for private-fund managers.
Who you will face today
- Your GP clients
Carrying: Secondaries Investor reports increasing SEC examination requests for details on specific private-fund valuations and rising enforcement activity
Ask: If an examiner asked for the full support behind a material mark today, which outside valuation, finance or governance specialist would help your team pressure-test the record? - Your Operating Partner clients
Carrying: ACG Insights reports that middle-market debt coverage has rebounded, while lender pricing remains structurally higher than before 2022
Ask: Suppose a deal team needs to re-underwrite a platform under today’s debt costs, where would a fractional finance or commercial diligence leader add the most decision-useful work? - Your Portfolio CEO clients
Carrying: PE Hub reports that Marlin’s Radar Healthcare completed an add-on acquisition of patient-experience platform Cemplicity
Ask: If your company were closing an add-on like Radar Healthcare’s Cemplicity acquisition, who would own the first 100 days of integration across product, customers and leadership?
Signal/Noise Ratio: 55/100 · Mixed Signal